Company Cell Biotech Co., Ltd.

Equities

A049960

KR7049960008

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 23:00:00 03/07/2024 BST			5-day change	1st Jan Change
13,250 ^KRW	+0.91%		+2.71%	+18.09%

2023	Cell Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.	CI

CELLBIOTECH Co., Ltd is a Korea-based company engaged in the manufacturing of bio products. The Company's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 122

KRW in Million	2022	Weight	2023	Weight	Delta
Finished Product 90.4 %	44,729	88.5 %	48,603	90.4 %	+8.66%
Raw Powder 9.6 %	5,797	11.5 %	5,184	9.6 %	-10.58%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 51.8 %	27,193	53.8 %	27,851	51.8 %	+2.42%
Europe 29.6 %	12,980	25.7 %	15,932	29.6 %	+22.75%
Others 18.6 %	10,353	20.5 %	10,004	18.6 %	-3.37%

Managers	Title	Age	Since
Myoung-Joon Jeong CEO	Chief Executive Officer	66	29/03/22
Young-Ok Yoon BRD	Director/Board Member	61	-
Seong-Bae Yoon BRD	Director/Board Member	59	-
Yu-Min Eun PRN	Corporate Officer/Principal	53	-
Young-Sook Song AUD	Comptroller/Controller/Auditor	61	-

Members of the board	Title	Age	Since
Myoung-Joon Jeong CEO	Chief Executive Officer	66	29/03/22
Seong-Bae Yoon BRD	Director/Board Member	59	-
Young-Ok Yoon BRD	Director/Board Member	61	-
Kwang-Sun No BRD	Director/Board Member	60	20/03/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,400,000	4,485,327 ( 47.72 %)	2,556,100 ( 27.19 %)	47.72 %

Name	Equities	%	Valuation
CELL BIOTECH CO., LTD. 27.19 %	2,556,100	27.19 %	22 M ₩
Myoung-Joon Jeong 18.49 %	1,738,373	18.49 %	15 M ₩
Young-Ok Yoon 3.191 %	300,000	3.191 %	3 M ₩
Seong-Bae Yoon 2.489 %	234,000	2.489 %	2 M ₩
Yu-sook Jeong 0.4532 %	42,600	0.4532 %	371 371 ₩
Hye-ji Jeong 0.4532 %	42,600	0.4532 %	371 371 ₩
Niche Asset Management Ltd. 0.0266 %	2,500	0.0266 %	21 794 ₩
Yumin Lee 0.008691 %	817	0.008691 %	7 122 ₩

Name	Equities	%	Valuation
CELL BIOTECH CO., LTD. 27.19%	2,556,100	27.19%	22,283,134 $

Cell Biotech Co., Ltd.

50 Aegibong-ro 409beon-gil Wolgot-myeon

10003, Gimpo-si

http://www.cellbiotech.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
CELL BIOTECH CO., LTD.	+18.09%	64.91M
VERTEX PHARMACEUTICALS INCORPORATED	+15.58%	121B
REGENERON PHARMACEUTICALS, INC.	+16.60%	110B
ARGENX SE	+17.73%	25.93B
BIONTECH SE	-24.33%	19.27B
GENMAB A/S	-19.35%	16.01B
BEIGENE, LTD.	-17.95%	15.66B
WUXI APPTEC CO., LTD.	-48.32%	14.89B
SAREPTA THERAPEUTICS, INC.	+58.78%	14.47B
NEUROCRINE BIOSCIENCES, INC.	+4.91%	13.91B

Bio Therapeutic Drugs